Joshua Sabari
MD
Assistant Professor of Medicine
👥Biography 个人简介
Joshua Sabari investigates exon 20 insertion mutations in HER2 and EGFR in NSCLC, defining clinical characteristics and therapeutic strategies for this historically difficult-to-treat population. His work contributed to clinical development of amivantamab, mobocertinib, and novel HER2 exon 20 agents. He advances biomarker-guided trial enrollment for exon 20 alterations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Joshua Sabari 的研究动态
Follow Joshua Sabari's research updates
留下邮箱，当我们发布与 Joshua Sabari（NYU Langone Perlmutter Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment